Pfizer Isn't Dead Money, Pipeline Execution Can Spark A Rebound [Seeking Alpha]
Pfizer, Inc. (PFE)
Last pfizer, inc. earnings: 4/28 06:45 am
Check Earnings Report
US:NYSE Investor Relations:
investors.pfizer.com/investors-overview/default.aspx
Company Research
Source: Seeking Alpha
PFE's discounted valuation reflects worrying execution risks tied to COVID franchise headwinds, loss of exclusivity, and the need for robust pipeline execution in oncology and obesity. Management's focus is on advancing multiple Phase III studies and commercializing new assets, but near-term valuation upside is unlikely until clearer growth visibility emerges. Yet, robust free cash flow and a sustainable dividend payout ratio support PFE's income appeal, positioning it as a timely growth-plus-income opportunity for patient investors. Alexandros Michailidis/iStock Editorial via Getty Images Pfizer: Still Underperforming, But You Need To Give It Time If I am a Pfizer Inc. ( PFE ) investor (I used to be, nonetheless), I should have been "elated" at PFE's recent performance against the market, while still getting More on my IG service A Growth Investing Service To Help You Outperform I'm a firm believer in growth and tech plays as a core component of our portfolio. Our
Show less
Read more
Impact Snapshot
Event Time:
PFE
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
|
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
|---|---|---|
|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
| Last Price | ||
| VWAP | ||
|
High:
|
Max Up |
High:
|
|
Low:
|
Max Down |
Low:
|
|
%
|
Post news range |
%
|
|
|
Price change |
|
|
|
Price Change Percentage |
|
|
|
S&P 500 (SPX) |
|
|
%
|
Volume ratio |
%
|
| Volume | ||
| Ticks | ||
|
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
PFE alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
PFE alerts
High impacting Pfizer, Inc. news events
Weekly update
A roundup of the hottest topics
PFE
News
- Pfizer (PFE) CEO's Struggling Because Of “a Good Hand,” Says Jim Cramer [Yahoo! Finance]Yahoo! Finance
- Down 80%, Should You Buy the Dip on Moderna? [Yahoo! Finance]Yahoo! Finance
- Pfizer Invites Public to View and Listen to Webcast of February 3 Conference Call with AnalystsBusiness Wire
- If I Could Only Buy and Hold a Single Stock, This Would Be It [Yahoo! Finance]Yahoo! Finance
- Pfizer Adds to Its Big Bet on Weight Loss Drugs [Yahoo! Finance]Yahoo! Finance
PFE
Earnings
- 11/4/25 - Beat
PFE
Sec Filings
- 12/17/25 - Form 4
- 12/16/25 - Form 8-K
- 12/2/25 - Form 4
- PFE's page on the SEC website